You are viewing the site in preview mode

Skip to main content

Advertisement

Table 5 Summary of susceptibility profiles of aerobic bacteria

From: The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses

All gram-positive aerobes including Enterococcus spp.
Antibiotics Susceptible (%) Intermediate (%) Resistant (%) Total:
Ampicillin 21 (44.7) 0 (0) 26 (55.3) 47
Amox/Clav. 21 (44.7) 0 (0) 26 (55.3) 47
Pip/Taz. 21 (47.7) 0 (0) 23 (52.3) 44
Cefuroxime 12 (19.0) 0 (0) 51 (81.0)a 63
Cefotaxime 10 (20.4) 0 (0) 39 (79.6)a 49
Gentamycin 27 (51.9) 0 (0) 25 (48.1) 52
Tigecycline 42 (100) 0 (0) 0 (0) 42
Levofloxacin 21 (35.0) 2 (3.3) 37 (61.7) 60
Vancomycin 43 (76.8) 0 (0) 13 (23.2) 56
Imipenem 13 (34.2) 0 (0) 25 (65.8) 38
Linezolid 44 (97.8) 1 (2.2) 0 (0) 45
Enterococcus spp. only
Antibiotics Susceptible (%) Intermediate (%) Resistant (%) Total:
Ampicillin 12 (31.6) 0 (0) 26 (68.4) 38
Erythromycin 9 (25.0) 3 (8.3) 24 (66.7) 36
Imipenem 13 (34.2) 0 (0) 25 (65.8) 38
Tigecycline 32 (100) 0 (0) 0 (0) 32
Vancomycin 21 (60.0) 0 (0) 14 (40.0) 35
Teicoplanin 35 (92.1) 1 (2.6) 2 (5.3) 38
Levofloxacin 10 (26.3) 1 (2.6) 27 (71.1) 38
Linezolid 33 (97.1) 1 (2.9) 0 (0) 34
Daptomycin 7 (87.5) 0 (0) 1 (12.5) 8
All gram-negative aerobes
Antibiotics Susceptible (%) Intermediate (%) Resistant (%) Total:
Ampicillin 8 (15.1) 1 (1.9) 44 (83.0) 53
Amox/Clav 17 (33.3) 5 (9.8) 29 (56.9) 51
Pip/Taz 30 (52.6) 6 (10.5) 21 (36.8) 57
Cefuroxime 17 (33.3) 8 (15.7) 26 (51.0) 51
Cefotaxime 30 (60.0) 0 (0) 20 (40.0) 50
Ceftazidim 10 (66.7) (52.2) 2 (13.3) 3 (20.0) 15
Imipenem 53 (84.1) 3 (4.8) 7 11.1) 63
Meropenem 55 (90.2) 1 (1.6) 5 (8.2) 61
Gentamicin 52 (83.9) 0 (0) 10 (16.1) 62
Tigecycline 35 (71.4) 4 (8.2) 10 (20.4) 49
TMP/SMX 42 (73.7) 0 (0) 15 (26.3) 57
Levofloxacin 42 (68.9) 2 (3.3) 17 (27.9) 61
Ciprofloxacin 41 (68.3) 1 (1.7) 18 (30.0) 60
  1. Amox/Clav amoxicillin/clavulanic acid, Pip/Taz piperacillin/tazobactam, TMP/SMX trimethoprim/sulfamethoxazole
  2. a Enterococcus spp. with an intrinsic resistance